Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy

NCT05103306 · clinicaltrials.gov ↗

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Empagliflozin 25 MG
DRUG: INS

Sponsor

Chungbuk National University Hospital